FDA considers ‘competency-based’ evaluations for GenAI-enabled medical devices - MassDevice
Reported by MassDevice · all stories from massdevice.com
Editorial digest
The Food and Drug Administration is contemplating a 'competency-based' approach for assessing generative artificial intelligence in medical devices, focusing on what they can actually do.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at MassDevice →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/20/2026
FDA weighs regulatory approach for genAI medical devices - MobiHealthNews
The FDA is deliberating its regulatory strategy for generative AI medical devices.
- Trusted health newsroom8/18/2026
FDA seeks feedback on potential regulatory approaches for generative AI-enabled medical devices | AHA News - American Hospital Association
The FDA seeks input on regulating generative AI for medical devices.
- Trusted health newsroom8/18/2026
FDA considering doctor-like assessment for AI-enabled devices - Axios
The FDA is considering a doctor-like assessment method for AI-enabled medical devices.
- Trusted health newsroom10/22/2026
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Federal regulators have completed formal guidelines for software applications paired with medications, drawing positive reactions from pharmaceutical manufacturers.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.
- Reputable trade press8/19/2026
FDA Weighs Clinician-Style Tests for Generative AI Medical Devices - PYMNTS.com
FDA considers clinician-style evaluations for generative AI medical devices.